{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:02:40Z","timestamp":1777363360218,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.bioorg.2021.105238","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T05:59:44Z","timestamp":1628402384000},"page":"105238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4"],"prefix":"10.1016","volume":"115","author":[{"given":"Wang","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Ran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaojie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luoting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2021.105238_b0005","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cell.2012.02.013","article-title":"Histone recognition and large-scale structural analysis of the human bromodomain family","volume":"149","author":"Filippakopoulos","year":"2012","journal-title":"Cell"},{"issue":"7794","key":"10.1016\/j.bioorg.2021.105238_b0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"issue":"6489","key":"10.1016\/j.bioorg.2021.105238_b0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.aaz8455","article-title":"Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation","volume":"368","author":"Gilan","year":"2020","journal-title":"Science (New York, NY)."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105238_b0020","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/annonc\/mdw552","article-title":"Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism","volume":"28","author":"Morel","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bioorg.2021.105238_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108306","article-title":"BET bromodomains as novel epigenetic targets for brain health and disease","volume":"181","author":"Singh","year":"2020","journal-title":"Neuropharmacology."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105238_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111849","article-title":"The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins","volume":"17","author":"Taniguchi","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2021.105238_b0035","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.20533","article-title":"RNase H enables efficient repair of R-loop induced DNA damage","volume":"5","author":"Amon","year":"2016","journal-title":"Elife."},{"issue":"32","key":"10.1016\/j.bioorg.2021.105238_b0040","doi-asserted-by":"crossref","first-page":"E4448","DOI":"10.1073\/pnas.1512081112","article-title":"Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells","volume":"112","author":"Yoshida","year":"2015","journal-title":"PNAS"},{"issue":"1","key":"10.1016\/j.bioorg.2021.105238_b0045","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1038\/s41467-020-17503-y","article-title":"BRD4 prevents the accumulation of R-loops and protects against transcription-replication collision events and DNA damage","volume":"11","author":"Lam","year":"2020","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105238_b0050","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2021.105238_b0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2021.105238_b0060","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-020-0215-2","article-title":"Target gene-independent functions of MYC oncoproteins","volume":"21","author":"Baluapuri","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7327","key":"10.1016\/j.bioorg.2021.105238_b0065","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2021.105238_b0070","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2017-5071","article-title":"Preclinical characterization of the potent and selective BET inhibitor INCB057643 in models of hematologic malignancies","volume":"77","author":"Stubbs","year":"2017","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.bioorg.2021.105238_b0075","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1158\/1078-0432.CCR-18-0864","article-title":"Inhibition of BET Bromodomain Proteins with GS-5829 and GS-626510 in Uterine Serous Carcinoma, a Biologically Aggressive Variant of Endometrial Cancer","volume":"24","author":"Bonazzoli","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105238_b0080","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/acs.jmedchem.5b01882","article-title":"Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials","volume":"59","author":"Albrecht","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2021.105238_b0085","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2016-4694","article-title":"ABBV-075, a novel BET family inhibitor, disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo","volume":"76","author":"Faivre","year":"2016","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105238_b0090","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nm.4372","article-title":"Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors","volume":"23","author":"Janouskova","year":"2017","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2021.105238_b0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.molcel.2018.06.036","article-title":"DUB3 Promotes BET Inhibitor Resistance and Cancer Progression by Deubiquitinating BRD4","volume":"71","author":"Jin","year":"2018","journal-title":"Mol. Cell"},{"issue":"9","key":"10.1016\/j.bioorg.2021.105238_b0100","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4378","article-title":"Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4","volume":"23","author":"Dai","year":"2017","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105238_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4379","article-title":"Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation","volume":"23","author":"Zhang","year":"2017","journal-title":"Nat. Med."},{"issue":"7586","key":"10.1016\/j.bioorg.2021.105238_b0110","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature16508","article-title":"Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer","volume":"529","author":"Shu","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.bioorg.2021.105238_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.04.027","article-title":"Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer","volume":"78","author":"Shu","year":"2020","journal-title":"Molecular Cell."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105238_b0120","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1038\/s41467-020-16170-3","article-title":"Acquired resistance to combined BET and CDK4\/6 inhibition in triple-negative breast cancer","volume":"11","author":"Ge","year":"2020","journal-title":"Nat. Commun."},{"issue":"17","key":"10.1016\/j.bioorg.2021.105238_b0125","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1021\/acs.chemrev.7b00077","article-title":"Small-Molecule Modulation of Protein Homeostasis","volume":"117","author":"Burslem","year":"2017","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105238_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrd.2016.211","article-title":"Induced protein degradation: an emerging drug discovery paradigm","volume":"16","author":"Lai","year":"2017","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"6","key":"10.1016\/j.bioorg.2021.105238_b0135","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1002\/anie.201507978","article-title":"Small-Molecule PROTACS: New Approaches to Protein Degradation","volume":"55","author":"Toure","year":"2016","journal-title":"Angew. Chemie-Int. Ed."},{"issue":"15","key":"10.1016\/j.bioorg.2021.105238_b0140","doi-asserted-by":"crossref","first-page":"8554","DOI":"10.1073\/pnas.141230798","article-title":"Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation","volume":"98","author":"Sakamoto","year":"2001","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bioorg.2021.105238_b0145","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/acs.jmedchem.8b01572","article-title":"Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)","volume":"62","author":"Hu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2021.105238_b0150","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","article-title":"Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4","volume":"22","author":"Lu","year":"2015","journal-title":"Chem. Biol."},{"issue":"6241","key":"10.1016\/j.bioorg.2021.105238_b0155","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science (New York, NY)."},{"issue":"7327","key":"10.1016\/j.bioorg.2021.105238_b0160","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"issue":"26","key":"10.1016\/j.bioorg.2021.105238_b0165","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.1521738113","article-title":"PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer","volume":"113","author":"Raina","year":"2016","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.bioorg.2021.105238_b0170","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1021\/acschembio.5b00216","article-title":"Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4","volume":"10","author":"Zengerle","year":"2015","journal-title":"ACS Chem. Biol."},{"issue":"9","key":"10.1016\/j.bioorg.2021.105238_b0175","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-16-2622","article-title":"Targeted Degradation of BET Proteins in Triple-Negative Breast Cancer","volume":"77","author":"Bai","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bioorg.2021.105238_b0180","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jmedchem.6b01912","article-title":"Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds","volume":"61","author":"Chan","year":"2018","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105238_b0185","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1158\/0008-5472.CAN-16-1793","article-title":"Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic Strategies","volume":"77","author":"Bui","year":"2017","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.bioorg.2021.105238_b0190","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1158\/1078-0432.CCR-19-0578","article-title":"First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed\/Refractory Solid Tumors","volume":"25","author":"Piha-Paul","year":"2019","journal-title":"Clin Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2021.105238_b0195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","article-title":"BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment","volume":"67","author":"Winter","year":"2017","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bioorg.2021.105238_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/nchembio.2329","article-title":"Structural basis of PROTAC cooperative recognition for selective protein degradation","volume":"13","author":"Gadd","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"11","key":"10.1016\/j.bioorg.2021.105238_b0205","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1021\/jacs.5b12608","article-title":"On-Demand Targeting: Investigating Biology with Proximity-Directed Chemistry","volume":"138","author":"Long","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2021.105238_b0210","doi-asserted-by":"crossref","first-page":"105295","DOI":"10.1016\/j.phrs.2020.105295","article-title":"Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux","volume":"163","author":"Xia","year":"2021","journal-title":"Pharmacol. Res."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206821006155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:30:31Z","timestamp":1758616231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206821006155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":42,"alternative-id":["S0045206821006155"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105238","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2021.105238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105238"}}